CRP and exocrine pancreatic carcinoma: We utilised Kaplan−Meier survival curves based on the PF (Figures 1A, D) and CRP/Alb (Figures 1B, E), and they showed that increased levels of these markers were associated with decreased OS in both the entire group of pancreatic carcinoma patients and specifically in those diagnosed with PDAC.